Cargando…

A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy

Prostate cancer (PCa) testing involves a complex individually based decision making process. It should consider competing risks from other comorbidities when estimating a survival benefit from the early detection of clinically significant (cs)PCa. We aimed to develop a prediction tool that provides...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verbeek, Jan F.M., Nieboer, Daan, Parker, Chris, Kattan, Michael W., Steyerberg, Ewout W., Roobol, Monique J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617187/ https://www.ncbi.nlm.nih.gov/pubmed/31013571 http://dx.doi.org/10.3390/jpm9020019

Ejemplares similares

Personalized Decision Making for Biopsies in Prostate Cancer Active Surveillance Programs
por: Tomer, Anirudh, et al.
Publicado: (2019)

Shared decision making of burdensome surveillance tests using personalized schedules and their burden and benefit
por: Tomer, Anirudh, et al.
Publicado: (2022)

Personalised biopsy schedules based on risk of Gleason upgrading for patients with low‐risk prostate cancer on active surveillance
por: Tomer, Anirudh, et al.
Publicado: (2020)

Personalized schedules for surveillance of low‐risk prostate cancer patients
por: Tomer, Anirudh, et al.
Publicado: (2018)

Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome
por: Pereira-Azevedo, Nuno, et al.
Publicado: (2018)

Active surveillance: a review of risk-based, dynamic monitoring
por: Nieboer, Daan, et al.
Publicado: (2018)

Improving prediction models with new markers: a comparison of updating strategies
por: Nieboer, D., et al.
Publicado: (2016)

Predicting biochemical recurrence and prostate cancer‐specific mortality after radical prostatectomy: comparison of six prediction models in a cohort of patients with screening‐ and clinically detected prostate cancer
por: Remmers, Sebastiaan, et al.
Publicado: (2019)

The Patient Journey from Randomization to Detection of Prostate Cancer and Death: Results from ERSPC Rotterdam
por: Remmers, Sebastiaan, et al.
Publicado: (2023)

Reducing Biopsies and Magnetic Resonance Imaging Scans During the Diagnostic Pathway of Prostate Cancer: Applying the Rotterdam Prostate Cancer Risk Calculator to the PRECISION Trial Data
por: Remmers, Sebastiaan, et al.
Publicado: (2021)

Comparison of biopsy under‐sampling and annual progression using hidden markov models to learn from prostate cancer active surveillance studies
por: Li, Weiyu, et al.
Publicado: (2020)

Assessing Discriminative Performance at External Validation of Clinical Prediction Models
por: Nieboer, Daan, et al.
Publicado: (2016)

Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer
por: Venderbos, Lionne D. F., et al.
Publicado: (2015)

Updating the Rotterdam Prostate Cancer Risk Calculator with Invasive Cribriform and/or Intraductal Carcinoma for Men with a Prior Negative Biopsy
por: Remmers, Sebastiaan, et al.
Publicado: (2021)

Predicting Low-Risk Prostate Cancer from Transperineal Saturation Biopsies
por: van Leeuwen, Pim J., et al.
Publicado: (2016)

Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?
por: Osses, Daniël F., et al.
Publicado: (2020)

Assessment of heterogeneity in an individual participant data meta‐analysis of prediction models: An overview and illustration
por: Steyerberg, Ewout W., et al.
Publicado: (2019)

Multivariate risk prediction tools including MRI for individualized biopsy decision in prostate cancer diagnosis: current status and future directions
por: Schoots, Ivo G., et al.
Publicado: (2019)

Multivariable risk-based patient selection for prostate biopsy in a primary health care setting: referral rate and biopsy results from a urology outpatient clinic
por: Osses, Daniël F., et al.
Publicado: (2018)

Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database
por: Beckmann, Kerri R., et al.
Publicado: (2022)

Personalized Decision Making on Genomic Testing in Early Breast Cancer: Expanding the MINDACT Trial with Decision-Analytic Modeling
por: Steyerberg, Ewout W., et al.
Publicado: (2021)

Performance of IMPACT, CRASH and Nijmegen models in predicting six month outcome of patients with severe or moderate TBI: an external validation study
por: Majdan, Marek, et al.
Publicado: (2014)

Validation of prediction models: examining temporal and geographic stability of baseline risk and estimated covariate effects
por: Austin, Peter C., et al.
Publicado: (2017)

Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group
por: Roobol, Monique J., et al.
Publicado: (2011)

Peritoneal dialysis after shared decision-making: the disparity between reality and patient expectations
por: Ho, Ya-Fang, et al.
Publicado: (2022)

Incorporating natural variation into IVF clinic league tables: The Expected Rank
por: Lingsma, Hester F, et al.
Publicado: (2009)

Identifying trauma patients with benefit from direct transportation to Level-1 trauma centers
por: Sewalt, Charlie A., et al.
Publicado: (2021)

Expect the Worst! Expectations and Social Interactive Decision Making
por: Giorgetta, Cinzia, et al.
Publicado: (2021)

What is an acceptable false negative rate in the detection of prostate cancer?
por: Verbeek, Jan F. M., et al.
Publicado: (2018)

Comparison of clinically significant prostate cancer detection by MRI cognitive biopsy and in-bore MRI-targeted biopsy for naïve biopsy patients
por: Zhang, Kai, et al.
Publicado: (2020)

Quality Improvement Initiatives in Renal Biopsy for Patient-Centered Communication by Shared Decision Making
por: Chen, Cheng-Hsu, et al.
Publicado: (2022)

A personalized decision aid for prostate cancer shared decision making
por: Bagshaw, Hilary P., et al.
Publicado: (2021)

From shared decision making to patient-centered decision making
por: Fineberg, Harvey V
Publicado: (2012)

Focus on shared decision‐making
por: Chew‐Graham, Carolyn A.
Publicado: (2017)

The limits of shared decision making
por: Elwyn, Glyn, et al.
Publicado: (2023)

Shared decision making between patient and GP about referrals from primary care: Does gatekeeping make a difference?
por: Rotar, Alexandru M., et al.
Publicado: (2018)

Development of a prediction model in female pure or predominant urge urinary incontinence: a retrospective cohort study
por: van Doorn, Tess, et al.
Publicado: (2022)

‘Triadic’ shared decision making in mental health: Experiences and expectations of service users, caregivers and clinicians in Germany
por: Schuster, Florian, et al.
Publicado: (2021)

Shared Decision Making: The 9-Item Shared Decision Making Questionnaire Does Not Discriminate Between Surgeons
por: Reese, Alyssa, et al.
Publicado: (2021)

Prostate-specific antigen kinetics contributes to decision making for biopsy referral: the predictive implication for PSA retest in patients with elevated PSA levels
por: Kobayashi, Minoru, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6142ohg55v21mrdvgdmq8340d0